Geriatrics
Long Covid: Largest post-acute COVID-19 study to date examined the health outcomes in more than 73,000 people who’d had COVID-19 and were not hospitalized
23 Apr, 2021 | 08:48h | UTCHigh-dimensional characterization of post-acute sequalae of COVID-19 – Nature
Commentary on Twitter (thread – click for more)
Happy to share the latest paper from our team in @nature
A comprehensive characterization of post acute sequelae of COVID-19#longcovid #PASChttps://t.co/AGLnYCamWe@VAResearch @vahsrd @WUSTL @WUSTLpubhealth @WUSTLmed @WUSTLnews @VREFSTL @Biostayan @BCBowe
— Ziyad Al-Aly, MD (@zalaly) April 22, 2021
Podcast: Dementia Made Simple
20 Apr, 2021 | 05:21h | UTC#268 Dementia Made Simple with Dr. Josh Uy – The Curbsiders
Evolving changes in mortality of 13,301 critically ill adult patients with COVID-19 over 8 months
16 Apr, 2021 | 06:35h | UTC
Commentary on Twitter
Our paper on covid-19 pandemic trends in the first 8 months in the pandemic at @yourICM. Patients are getting younger, less frail, and mortality decreased over time. Very poor outcomes for elder frail patients. https://t.co/DHJvr22zFl
— Fernando Zampieri (@f_g_zampieri) April 14, 2021
USPSTF Statement: Insufficient evidence to recommend Vitamin D deficiency screening
14 Apr, 2021 | 01:47h | UTCVitamin D Deficiency in Adults: Screening – U.S. Preventive Services Task Force
Evidence Report: Screening for Vitamin D Deficiency in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force
Editorial: The USPSTF 2021 Recommendations on Screening for Asymptomatic Vitamin D Deficiency in Adults: The Challenge for Clinicians Continues – JAMA AND Why USPSTF Still Finds Insufficient Evidence to Support Screening for Vitamin D Deficiency – JAMA Network Open
JAMA Patient Page: Screening for Vitamin D Deficiency in Adults
Guidance: Using Ventilation and filtration to reduce aerosol transmission of COVID-19 in long-term care homes
15 Apr, 2021 | 06:54h | UTC
Commentary on Twitter
PHAC guidance updated yesterday emphasizes aerosol transmission (including fecal aerosol via toilet traps) and need for adequate ventilation and/or air cleaners (HEPA). We are getting there.@jljcolorado @linseymarr @kprather88 https://t.co/8hi77846cY
— David Fisman (@DFisman) April 14, 2021
Cohort study: Higher cumulative exposure to Thiazide diuretics linked to an increased risk of skin cancer in people older than 65 years
13 Apr, 2021 | 05:08h | UTCCommentaries: Thiazides May Up Risk for Skin Cancer in Older Adults – HealthDay AND Some blood pressure medication linked to higher risk of skin cancer, study finds – CTV News
Related study: Case-Control Study: Possible Association of Hydrochlorothiazide Use and Risk of Melanoma
Study: Protocoled time-limited trials among critically ill patients with advanced medical illnesses were associated with reduction of nonbeneficial ICU treatments
13 Apr, 2021 | 05:16h | UTCEvaluation of Time-Limited Trials Among Critically Ill Patients With Advanced Medical Illnesses and Reduction of Nonbeneficial ICU Treatments – JAMA Internal Medicine (free for a limited period)
Commentary: Time-Limited Trials and Potentially Nonbeneficial Treatment in the ICU—Willing to Wait for It – JAMA Internal Medicine AND Time-limited trials may decrease the length of stay of critically ill patients in the intensive care unit – 2 Minute Medicine
Author interview: Time-Limited Trials Among Patients With Advanced Illness to Reduce Nonbeneficial ICU Treatments
Related review: Time-limited trial of intensive care treatment: an overview of current literature – Intensive Care Medicine
Long-term mortality of elderly patients after intensive care unit admission for COVID-19
14 Apr, 2021 | 02:09h | UTC
Commentary on Twitter
Long-term outcome of elderly (≥ 80y) #COVID19 pts admitted to #ICU: 6-month mortality ➡️ 72% (likely underestimated) at upper end of recent literature on older critical pts. Data supporting more informed goals-of-care decisions for this #SARSCoV2 cohort?https://t.co/mIKNxNpdC8 pic.twitter.com/OQS5SN5FXR
— Intensive Care Medicine (@yourICM) April 13, 2021
Cohort Study: Effects of fluoroquinolones on outcomes of patients with aortic dissection or aneurysm
13 Apr, 2021 | 05:05h | UTCRelated: Another study suggests fluoroquinolone use may increase the risk of development of aortic aneurysms (study and commentaries) AND Link between fluoroquinolones, aorta problems may not be as strong as thought AND Study: Oral Fluoroquinolones and Risk of Mitral and Aortic Regurgitation AND FDA Warns About Increased Risk of Aortic Dissection and Ruptures of Aortic Aneurism with Fluoroquinolones AND Meta-analysis: Fluoroquinolones and the Risk of Aortopathy AND Study: Oral Fluoroquinolone and the Risk of Aortic Dissection AND Research: Fluoroquinolone use and risk of aortic aneurysm and dissection
Clinical Review: Screening and management of atrial fibrillation in primary care
13 Apr, 2021 | 05:09h | UTCScreening and management of atrial fibrillation in primary care – The BMJ
AHA/ASA Scientific Statement: Perioperative Neurological Evaluation and Management to Lower the Risk of Acute Stroke in Patients Undergoing Noncardiac, Nonneurological Surgery
12 Apr, 2021 | 00:50h | UTC
Commentary on Twitter
NEW GUIDELINE – now codifies what has been discussed for a while "If history of stroke exists, consider delaying elective surgery at least 6 mo
and preferably 9 mo from time of incident stroke." @SPAQIedu @LeeAFleisher @preopconsult @afedwardMD https://t.co/0ewdlPGVlj— Kurt Pfeifer (@KurtPfeifer) April 9, 2021
RCT: Among patients with peripheral artery disease, low-intensity exercise was significantly less effective than high-intensity exercise for improving 6-minute walk distance
7 Apr, 2021 | 01:31h | UTCEffect of Low-Intensity vs High-Intensity Home-Based Walking Exercise on Walk Distance in Patients With Peripheral Artery Disease: The LITE Randomized Clinical Trial – JAMA (free for a limited period)
Commentary on Twitter
In this RCT of patients with PAD, low-intensity home-based exercise was less effective than high-intensity home-based exercise, and similar to the nonexercise control, for improving 6-min walk distance https://t.co/dVWCDx5hLM @NUFeinbergMed @StanfordMed @UChicagoMed @wakehealth
— JAMA (@JAMA_current) April 6, 2021
Cohort study: Risk of suicide attempt in patients with recent diagnosis of mild cognitive impairment or dementia
7 Apr, 2021 | 01:08h | UTCRisk of Suicide Attempt in Patients With Recent Diagnosis of Mild Cognitive Impairment or Dementia – JAMA Psychiatry (link to abstract – $ for full-text)
Commentaries: Recent Diagnosis of Cognitive Impairment, Dementia May Increase Suicide Risk – Psychiatric News Alert AND Suicide Attempts Spike Soon After Dementia Diagnosis – HealthDay
M-A: Non-drug therapies as good as or better than drugs for treating depression in people with dementia
2 Apr, 2021 | 09:05h | UTCCommentaries: Non-drug therapies as good as or better than drugs for treating depression in people with dementia – The BMJ AND Social prescribing may help reduce symptoms of depression in people with dementia – The BMJ Opinion AND Nondrug Interventions Can Help Alleviate Depression in Dementia Patients – HealthDay
ERC and ESICM Guidelines: Post-resuscitation Care
26 Mar, 2021 | 08:41h | UTC
Commentary on Twitter
Post #resuscitation @ERC_resus @ESICM guidelines #resus21
🫀diagnosis & reperfusion
🫀post CA syndrome
🫀hemodynamics
🫁oxygenation/ventilation
🧠general #ICU approach
🧠seizures control
🌡️TTM
🧠prognosis & outcome
💪#ICUrehab
🫁organ donation
🏥CA centershttps://t.co/BrPJtKw8vo pic.twitter.com/xS0FKFSK6F— Intensive Care Medicine (@yourICM) March 25, 2021
USPSTF Statement: Current evidence is insufficient to recommend screening for hearing loss in older adults
24 Mar, 2021 | 08:12h | UTCScreening for Hearing Loss in Older Adults – U.S. Preventive Services Task Force
Editorial: Screening for Hearing Loss in Older Adults: Insufficient Evidence Does Not Mean Insufficient Benefit – JAMA AND United States Preventive Services Task Force Recommendation for Hearing-Loss Screening Among Older Adults: An Opportunity in Insufficient Evidence – AMA Otolaryngology-Head & Neck Surgery AND USPSTF Recommendations for Hearing Loss Screening in Asymptomatic Older Adults—A Case of Missing Evidence and Missing Treatment Options – JAMA Network Open
Evidence Report: Screening for Hearing Loss in Older Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force – JAMA
Author interview: USPSTF Recommendation: Screening for Hearing Loss in Older Adults – JAMA
JAMA Patient Page: Screening for Hearing Loss in Older Adults
WHO Report: Kicking off a global conversation about ageism
19 Mar, 2021 | 08:12h | UTCGlobal report on ageism – World Health Organization
News release: Kicking off a global conversation about ageism: launch of the first UN Global report on ageism – World Health Organization
M-A: Cholinesterase inhibitors for vascular dementia and other vascular cognitive impairments
19 Mar, 2021 | 07:52h | UTC
Population Study: Past Covid-19 confers 80.5% protection against reinfection, which decreases to 47.1% in those aged 65 years and older
18 Mar, 2021 | 09:06h | UTCCommentaries: Risk of SARS-CoV-2 reinfection after natural infection – The Lancet AND COVID-19 Reinfection: More Common Than We Think? – MedPage Today (free registration required)
Commentary on Twitter
NEW—Most people who have had original #COVID19 strain are protected from catching it again for at least 6 months—but those ≥65 years are more prone to reinfection, suggests first large-scale study of its kind. Read https://t.co/250Yv0a9BZ pic.twitter.com/BTjhcMzXwT
— The Lancet (@TheLancet) March 17, 2021
RCT: No benefit from marine Omega-3 fatty acid and Vitamin D supplementation on incident atrial fibrillation
17 Mar, 2021 | 02:38h | UTCEffect of Marine Omega-3 Fatty Acid and Vitamin D Supplementation on Incident Atrial Fibrillation: A Randomized Clinical Trial – JAMA (free for a limited period)
Editorial: Omega-3 Fatty Acids and Atrial Fibrillation – JAMA (free for a limited period)
Systematic review | Hospital at home: home‐based end‐of‐life care
17 Mar, 2021 | 02:31h | UTCHospital at home: home‐based end‐of‐life care – Cochrane Library
Summary: Home-based end-of-life care – Cochrane Library
Meta-analysis of randomized trials bring into question the belief that betablockers cause depression
16 Mar, 2021 | 01:47h | UTCDo β-Blockers Cause Depression? Systematic Review and Meta-Analysis of Psychiatric Adverse Events During β-Blocker Therapy – Hypertension (link to abstract – $ for full-text)
News release: Beta-blockers not likely to cause depression yet may contribute to sleep disturbances – American Heart Association
Commentary: Beta blockers not associated with risk of depression – Charité – Universitätsmedizin Berlin
Central nervous system–active polypharmacy common among older adults with dementia in the US
16 Mar, 2021 | 01:45h | UTCPrevalence of Central Nervous System–Active Polypharmacy Among Older Adults With Dementia in the US – JAMA (free for a limited period)
Commentaries: CNS-Active Polypharmacy Examined in Seniors With Dementia – HealthDay AND A Trio That Could Spell Trouble: Many with Dementia Take Risky Combinations of Medicines – Michigan Medicine – University of Michigan AND Older Adults With Dementia at Risk From Taking Multiple Psychotropics, Study Suggests – Psychiatric News Alert
Commentary on Twitter
In this cross-sectional study of Medicare claims, 14% of older adults with dementia filled prescriptions consistent with CNS-active polypharmacy in 2018 (eg 3+ antidepressants, antipsychotics, BNZ, Z-drugs, or opioids) https://t.co/85BmGgeYil @dtmaust @umichmedicine @PennMedicine
— JAMA (@JAMA_current) March 9, 2021
Phase 2 RCT: Donanemab in early Alzheimer’s Disease
14 Mar, 2021 | 20:21h | UTCDonanemab in Early Alzheimer’s Disease – New England Journal of Medicine (link to abstract – $ for full-text)
Commentaries: Experimental Alzheimer’s drug could slow cognitive decline in patients, early results suggest – CNN AND Alzheimer’s study shows mixed results for Lilly’s donanemab on secondary outcomes – First World Pharma
Commentary on Twitter
In a phase 2 trial, patients with early Alzheimer’s disease who received donanemab, an antibody that targets amyloid deposits, showed a better composite score for cognition & ability to perform activities of daily living at 76 weeks than those who received placebo. #ADPD2021
— NEJM (@NEJM) March 13, 2021
M-A: Little benefit from antidepressants for low back pain
11 Mar, 2021 | 08:02h | UTCCommentary: Antidepressants provide no important benefits for managing low back pain – News Medical
Related meta-analysis: Little benefit from antidepressants for the treatment of back pain and osteoarthritis (study and commentaries)


